Difference between revisions of "Interorganizational SEND"

From PHUSE Wiki
Jump to: navigation, search
(Accomplished)
(Accomplished)
 
(14 intermediate revisions by the same user not shown)
Line 8: Line 8:
  
 
==Accomplished==
 
==Accomplished==
 +
* Between March 2014 and March 2015
 +
:* Survey of industry ''SEND data from Small/Medium Service Providers: How prepared are they to supply data in SEND format?''
 +
:* Template to Facilitate Creating Pharmacokinetic SEND datasets
 +
::* [[File:PC_template_with_formulas.xlsx]]
 +
 +
 
* Between March 2013 and March 2014
 
* Between March 2013 and March 2014
 
:* Summaries of actual experience with scenarios [[Scenario Experience]]
 
:* Summaries of actual experience with scenarios [[Scenario Experience]]
Line 19: Line 25:
 
::* [[SEND_Implementation_Wiki_-_SEND_between_Organizations]]
 
::* [[SEND_Implementation_Wiki_-_SEND_between_Organizations]]
 
::*[[File:PP08_Selecting_a_CRO_for_SEND.pdf]]
 
::*[[File:PP08_Selecting_a_CRO_for_SEND.pdf]]
:* The role of GLP in SEND files [[File:PP12_Quality_System_for SEND.pdf]]
+
:* The role of GLP in SEND files http://www.phusewiki.org/wiki/images/d/d7/PP12_Quality_System_for_SEND_-_flat.pdf
 
 
  
 
* Between March 2012  and March 2013
 
* Between March 2012  and March 2013
Line 30: Line 35:
  
 
==Plans==
 
==Plans==
By March 2015:
+
At the March 2015 meeting:
*Create a template for PC/PP data to provide organizations without SEND capabilities a way to provide TK data in a format that can more easily be integrated into a set of SEND datasets for a study.
+
*It was determined that the remaining tasks envisioned for this group are a lower priority than the other pressing needs for collaboration in nonclinical computational sciences.  As a result this project is complete.
:*Create the template
+
* The following items were considered as the next work for this team; so, as priorities adjust in the future, these may be worked on again:
:*Pilot its use
+
:*Create a template for PP data and enhance the PP template to provide organizations without SEND capabilities a way to provide TK data in a format that can more easily be integrated into a set of SEND datasets for a study.
:*Create a "points to consider" list
+
::*Pilot its use
:*Adjust the template as needed
+
::*Create a "points to consider" list
:*Publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.
+
::*Adjust the template as needed
*Evaluate the applicability of other CDISC standards CDASH, ADaM, ODM for non-clinical studies and publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.
+
::*Publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.
 
+
:*Evaluate the applicability of other CDISC standards CDASH, ADaM, ODM for non-clinical studies and publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.
==Participation Needs==
 
In 2014 as we will continue this work,  we will need participation from individuals with the following areas of expertise with an interest and ideally gaining some experience exchanging data or reports with other organizations to contribute to this effort:
 
*Scientists
 
*IT Specilists
 
*SEND implementers
 
*GLP QA auditors
 
 
 
'''What is the commitment?'''
 
* Time - will vary widely (minimum of 1 hour every two to four weeks for team meetings, up to 4-8 hours / month)
 
* Expected to contribute, not just be a spectator
 
 
 
'''If you would like to participate''', please contact the co-leads for this group:
 
*Debra Oetzman (debra.oetzman@covance.com)
 
*William Houser (william.houser@bms.com)
 
 
 
==Communications==
 
 
 
1 telecon every 4 weeks at the same time. One such meeting is 2pm Eastern Jun 23, 2014.
 
  
 
==Project Team==
 
==Project Team==
 
:*Pranav Agnihotri, PointCross
 
:*Pranav Agnihotri, PointCross
 
:*Kenjie Amemiya, Genentech
 
:*Kenjie Amemiya, Genentech
 +
:*Brian Argo, MPI Research
 +
:*Rich, Buchanan, Preclinical Data Systems
 
:*Kathryn Brown, Sanofi
 
:*Kathryn Brown, Sanofi
 
:*Susan DeHaven, Sanofi
 
:*Susan DeHaven, Sanofi
Line 66: Line 55:
 
:*Jennifer Feldmann, Instem
 
:*Jennifer Feldmann, Instem
 
:*Jeff Foy, Celgene
 
:*Jeff Foy, Celgene
:*Liz Graham, MPI Research
 
 
:*Geoff Ganem, Genentech
 
:*Geoff Ganem, Genentech
:*Erika Gigante, Amgen
 
 
:*Nancy Gongliewski, Novartis
 
:*Nancy Gongliewski, Novartis
 +
:*Elizabeth Gram, Zoetis
 
:*William Houser, Bristol-Myers Squibb
 
:*William Houser, Bristol-Myers Squibb
 +
:*George Kahlbaugh, Boehringer-Ingelheim
 
:*Laura Kaufman, Preclinical Data Systems
 
:*Laura Kaufman, Preclinical Data Systems
:*Jyotsna Kasturi, Johnson & Johnson
+
:*Rihab Kordane, Charles River Laboratory
 
:*Lou Ann Kramer, Eli Lilly
 
:*Lou Ann Kramer, Eli Lilly
 
:*Wayne Kung, Genentech
 
:*Wayne Kung, Genentech
 
:*Carolyn McGary, Bristol-Myers Squibb
 
:*Carolyn McGary, Bristol-Myers Squibb
:*Maureen Rossi, Roche
 
 
:*Connie Marvel, Bristol-Myers Squibb
 
:*Connie Marvel, Bristol-Myers Squibb
 
:*Shree Nath, PointCross
 
:*Shree Nath, PointCross
Line 84: Line 72:
 
:*Kathleene Powers, Pfizer
 
:*Kathleene Powers, Pfizer
 
:*Gerard Randoph, Roche
 
:*Gerard Randoph, Roche
 +
:*Maureen Rossi, Roche
 
:*Lynda Sands, GlaxoSmithKline  
 
:*Lynda Sands, GlaxoSmithKline  
 
:*Paul Sidney, Charles River Laboratory
 
:*Paul Sidney, Charles River Laboratory
Line 89: Line 78:
 
:*Troy Smyrnios, Zoetis
 
:*Troy Smyrnios, Zoetis
 
:* Eric Sun, Sanofi
 
:* Eric Sun, Sanofi
:*Nathan VanSweden, MPI Research
+
:* Kevin Trimm, Charles River Laboratory
 
:*Audrey Walker, Charles River Laboratory
 
:*Audrey Walker, Charles River Laboratory
 
:*Heather Williamson, PointCross
 
:*Heather Williamson, PointCross

Latest revision as of 12:30, 14 March 2016

Interorganizational SEND Project

Welcome to the Wiki for our project to identify challenges and propose solutions to help Sponsors and CROs, to work efficiently together, in a world where nonclinical data, possibly derived from different organizations, will be required to be aggregated in SEND format, for submission to the FDA.

Need/Challenge

The responsibilities for creating the SEND files for a study is often shared across organizations. Clarity is needed on how these responsiblities can be effectively managed.

Accomplished

  • Between March 2014 and March 2015
  • Survey of industry SEND data from Small/Medium Service Providers: How prepared are they to supply data in SEND format?
  • Template to Facilitate Creating Pharmacokinetic SEND datasets


  • Between March 2013 and March 2014
  • Points to consider list when preparing to create SEND datasets for studies that involve multiple organizations:
  • Between March 2012 and March 2013
  • We developed a framework to classify and prioritize scenarios in which data from multiple orginzations needs to be aggregated.
  • We selected 3 scenarios and for each developed workfows "on-paper" to create and submit SEND datasets.
  • While considering these scenarios we identified several questions that needed to be answered and collaberatively developed answers. These have been published on the PhUSE SEND User's Group wiki: Handling of SEND in Study Documentation
  • We started preparing a Scenarios White Paper
  • We published a poster at the 2013 FDA/PhUSE Computational Science Symposium, which is available as slides File:I-SEND Poster 2013 as slides.pdf

Plans

At the March 2015 meeting:

  • It was determined that the remaining tasks envisioned for this group are a lower priority than the other pressing needs for collaboration in nonclinical computational sciences. As a result this project is complete.
  • The following items were considered as the next work for this team; so, as priorities adjust in the future, these may be worked on again:
  • Create a template for PP data and enhance the PP template to provide organizations without SEND capabilities a way to provide TK data in a format that can more easily be integrated into a set of SEND datasets for a study.
  • Pilot its use
  • Create a "points to consider" list
  • Adjust the template as needed
  • Publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.
  • Evaluate the applicability of other CDISC standards CDASH, ADaM, ODM for non-clinical studies and publish the results on the PhUSE SEND Wiki and at the 2015 PhUSE/FDA Computational Sciences Symposium.

Project Team

  • Pranav Agnihotri, PointCross
  • Kenjie Amemiya, Genentech
  • Brian Argo, MPI Research
  • Rich, Buchanan, Preclinical Data Systems
  • Kathryn Brown, Sanofi
  • Susan DeHaven, Sanofi
  • Steven Denham, MPI Research
  • Jennifer Feldmann, Instem
  • Jeff Foy, Celgene
  • Geoff Ganem, Genentech
  • Nancy Gongliewski, Novartis
  • Elizabeth Gram, Zoetis
  • William Houser, Bristol-Myers Squibb
  • George Kahlbaugh, Boehringer-Ingelheim
  • Laura Kaufman, Preclinical Data Systems
  • Rihab Kordane, Charles River Laboratory
  • Lou Ann Kramer, Eli Lilly
  • Wayne Kung, Genentech
  • Carolyn McGary, Bristol-Myers Squibb
  • Connie Marvel, Bristol-Myers Squibb
  • Shree Nath, PointCross
  • Louis Norton, Covance
  • Debra Oetzman, Covance
  • Daniel Potenta, Novartis
  • Kathleene Powers, Pfizer
  • Gerard Randoph, Roche
  • Maureen Rossi, Roche
  • Lynda Sands, GlaxoSmithKline
  • Paul Sidney, Charles River Laboratory
  • Jared Slain, MPI Research
  • Troy Smyrnios, Zoetis
  • Eric Sun, Sanofi
  • Kevin Trimm, Charles River Laboratory
  • Audrey Walker, Charles River Laboratory
  • Heather Williamson, PointCross
  • Peggy Zorn, INDS

Conference Calls and Minutes

Interorganizational SEND Minutes

Last revision by William.houser,03/14/2016